The management of rosacea

Area of Science:

• Dermatology
• Pharmacology

Background:

• Rosacea is a complex skin condition with distinct phases: flushing, erythrosis, papulopustular rosacea, and phymas.
• Each phase of rosacea may necessitate individualized treatment strategies for optimal patient outcomes.

Purpose of the Study:

• To review current and potential therapeutic approaches for the diverse manifestations of rosacea.
• To highlight the importance of phase-specific treatments and ongoing research into rosacea etiology and management.

Main Methods:

• Literature review of existing studies on rosacea treatments.
• Analysis of pharmacological interventions, including topical and systemic medications.
• Evaluation of procedural treatments like lasers and surgery.

Main Results:

• Flushing may benefit from prophylactic beta-blockers (e.g., atenolol) or clonidine.
• Erythrosis can be managed with topical metronidazole or azelaic acid, and potentially by eradicating Helicobacter pylori.
• Papulopustular rosacea treatments include systemic antibiotics (metronidazole, doxycycline) and topical agents, with ivermectin showing promise.
• Telangiectases are treatable with specific lasers, and ocular rosacea with antibacterials.
• Phymas, particularly rhinophyma, often require surgical or laser-based dermatosurgical procedures.

Conclusions:

• A multi-faceted approach is crucial for managing rosacea, addressing each clinical presentation.
• Further research into the role of factors like Helicobacter pylori and Demodex folliculorum is warranted.
• Investigating prophylactic strategies for flushing and refining treatments for all rosacea subtypes remain key research priorities.